Helicobacter pylori, obesity and gastro-oesophageal reflux disease. Is there a relation? A personal view

Netherlands Journal of Medicine

Volumn 63, Issue 9, 2005, Pages 344-347

  Loffeld, R J L F ^a  

^a ZAANS MEDICAL CENTER   (Netherlands)

Author keywords

Gastro oesophageal reflux disease; Ghrelin; H. pylori; Leptin; Obesity

Indexed keywords

GHRELIN; LEPTIN;

BODY MASS; BODY WEIGHT; CALORIC INTAKE; DIETARY INTAKE; DISEASE ASSOCIATION; ERADICATION THERAPY; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INCIDENCE; INCREASED APPETITE; OBESITY; PREVALENCE; REVIEW; STOMACH FUNDUS; TISSUE LEVEL; WEIGHT GAIN; WEIGHT REDUCTION;

GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; OBESITY;

EID: 28644441262     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. El-Serag HB. The epidemic of esophageal adenocarcinoma. Gastroenterol Clin North Am 2002;31:421-40.
2. Sonnenberg A. El-Serag HB. Clinical epidemiology and natural history of gastroesophageal reflux disease. Yale J Biol Med 1999;72:81-92.
3. El-Seraq HB, Johanson JF. Risk factors for the severity of erosive esophagitis in Helicobacter pylori-negative patients with gastroesophageal reflux disease. Scand J Gastroenterol 2002;37:899-904.
4. Werdmuller B, van der Putten ABMM, Loffeld RJLF. The presentation of gastroesophageal reflux disease: a prospective clinical and endoscopic study. Dis of the Esophagus 1996;9:285-9.
5. Sugerman HJ. Effects of increased intra-abdominal pressure in severe obesity. Surg Clin North Am 2001;81:1063-75.
6. Lundell L, Ruth M, Sandberg N, Bove-Nielson M. Does massive obesity promote abnormal gastroesophageal reflux? Dig Dis Sci 1995;40:1632-5.
7. Madisch A, Weihs C, Schlaud M, Heimann D, Meyer H, Hotz J. The body mass index (BMI) has no impact on the frequency of typical reflux symptoms- results of a nationwide telephone-based informing campaign in Germany. Zentrallbl Chir 2002;127:1064-7.
8. Fisher BL, Pennathur A, Mutnick JL, Little AG. Obesity correlates with gastroesophageal reflux. Dig Dis Sci 1999;44:2290-4.
9. Ruhl CE, Everhart JE. Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: the NHANES I epidemiologic follow-up study first national health and nutrition examination survey. Ann Epidemiol 1999;9:424-35.
10. Foster A, Richards WO, McDowell J, Laws HL, Clements RH. Gastrointestinal symptoms are more intense in morbidly obese patients. Surg Endosc 2003;19:23-6.
11. Iovino P, Agrisani L, Tremolatteria I, Nirchio E, Ciarella M, Borrelli V, Sabbatini F, Mazzzacca G, Ciacci C. Abnormal esophageal acid exposure is common in morbidly obese patients and improves after successful Lap-ban system implantation. Surg Endosc 2002;16:1631-5.
12. Wilson LJ, Ma W, Hirschowitz BI. Association of obesity with hiatal hernia and esophagitis. Am J Gastroenterol 1999; 94:2840-4.
13. Nilsson M, Johnson R, Ye W, Hveem K, Lagergren J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 2003;290:66-72.
14. Murray L, Johnston B, Lane A, Harvey I, Donovan J, Nair P, Harvey R. Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter Project. Int J Epidemiol 2003;32:645-50.
15. Nilsson M, Lundegardh G, Carling L, Ye W, Lagergren J. Body mass and reflux oesophagitis: an estrogen-dependent association? Scand J Gastroenterol 2002;37:626-30.
16. Mayne ST. Navarro SA. Diet, obesity and reflux in the etiology of adenocarcinoma of esophagus and gastric cardia in humans. J Nutr 2002;132(11 suppl):3467-70.
17. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999;130:883-90.
18. Wajed SA, Streets CG, Bremner CG, DeMeester TR. Elevated body mass disrupts the barrier to gastroesophageal reflux. Arch Surg 2001;136:1014-8.
19. Loffeld RJ, van der Hulst RW. Helicobacter pylori and gastro-oesophageal reflux disease: association and clinical implications. To treat or not to treat with anti-H. pylori therapy. Scand J Gastroenterol suppl 2002;236:15-8.
20. Graham DY. Helicobacter pylori is not and never was 'protective' against anything, including GERD. Dig Dis Sci 2003;48:629-30.
21. Zentilin P, Liritano E, Vignale C et al. Helicobacter infection is not involved in the pathogenesis of either erosive or non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003;17:1057-64.
22. Cremonini F, Di Caro S, Delgado-Aros S et al. Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003;18:279-899.
23. Moss SF, Calam J. Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut 1993;34:888-92.
24. El-Omar E, Penman I, Darrion CA, Ardhill JS, McColl KEL. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut 1993;34:1060-5.
25. Sharma P. Helicobacter pylori: a debated factor in gastroesophageal reflux disease. Dig Dis 2001;19:127-33.
26. Sharma P, Vakil N. Review article: Helicobacter pylori and reflux disease. Aliment Pharmacol Ther 2003;17:297-305.
27. Labenz J, Blum AL, Bayerdorfer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442-7.
28. Kojima M, Hosoda H, Kangawa K. Ghrelin, a novel growth-hormone-releasing and appetite-stimulating peptide hormone from stomach. Best Pract Clin Endocrinol Metab 2004;18:517-30.
29. Osawa H, Nakazato M, Date Y, Kita H, Ohnishi H, Ueno H, Shiiya T, Satoh K, Ishino Y, Sugano K. Impaired production of gastric ghrelin an chronic gastritis associated with Helicobacter pylori. J Clin Endocrinol Metab 2005; 90(1):10-6.
30. Tatsuguchi A, Miyake K, Gudis K, Futagami S, Tsukiu T, Wada K, Fukuda Y, Sugisaki Y, Sakamoto C. Effect of Helicobacter pylori infection on ghrelin expression in human gastric mucosa. Am J Gastroenterol 2004;99:2121-7.
31. Gokcel A, Gumurdulu Y, Kayaselcuk F, Serin E, Ozer B, Ozsahin AK, Guvener N. Helicobacter pylori has no effect on plasma ghrelin levels. Eur J Endocrinol 2003;148:423-6.
32. Suzuki H, Masaoke T, Hosoda H, Ota T, Minegishi Y, Nomura S, Kangawa K, Ishii H. Helicobacter pylori infection modifies gastric and plasma ghrelin dynamics in Mongolian gerbils. Gut 2004;53:187-94.
33. Nwokolo U, Freshwater DA, O'Hare P, Randeva HS. Plasma ghrelin following cure of Helicobacter pylori. Gut 2003;52:637-40.
34. Jazet IM, Pijl H, Meinders AE. Adipose tissue as an endocrine organ: impact on insulin resistance. Neth J Med 2003;61:194-212.
35. Azuma T, Suto H, Oti Y, Ohtani M, Dojo M, Kuriyama M, Kato T. Gastric leptin and Helicobacter pylori infection. Gut 2001;49:324-9.